Tourmaline Bio reports strong financials, progress with clinical trials for pacibekitug in cardiovascular diseases.
From GlobeNewswire: 2025-03-13 07:30:00 Tourmaline Bio, Inc. announces financial results for Q4 and year ending December 31, 2024. They reported